{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T17:57:01Z","timestamp":1772819821756,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,8,17]],"date-time":"2007-08-17T00:00:00Z","timestamp":1187308800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1007\/s10067-007-0701-3","type":"journal-article","created":{"date-parts":[[2007,8,16]],"date-time":"2007-08-16T16:10:18Z","timestamp":1187280618000},"page":"289-294","source":"Crossref","is-referenced-by-count":36,"title":["Elevated serum receptor activator of NF\u03baB ligand (RANKL), osteoprotegerin (OPG), matrix metalloproteinase (MMP)3, and ProMMP1 in patients with juvenile idiopathic arthritis"],"prefix":"10.1007","volume":"27","author":[{"given":"Pradip Kumar","family":"Sarma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramnath","family":"Misra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amita","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,8,17]]},"reference":[{"key":"701_CR1","first-page":"34","volume":"27","author":"CE Rabinovich","year":"2000","unstructured":"Rabinovich CE (2000) Bone mineral status in juvenile rheumatoid arthritis. J Rheumatol 27:34\u201337","journal-title":"J Rheumatol"},{"key":"701_CR2","first-page":"1642","volume":"33","author":"P Aggarwal","year":"2006","unstructured":"Aggarwal P, Aggarwal A, Gupta S, Misra R (2006) Osteopenia is common in adult male patients with active juvenile idiopathic arthritis. J Rheumatol 33:1642\u20131645","journal-title":"J Rheumatol"},{"key":"701_CR3","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/1529-0131(200102)44:2<253::AID-ANR41>3.0.CO;2-S","volume":"44","author":"LC Hofbauer","year":"2001","unstructured":"Hofbauer LC, Heufelder AE (2001) A role of osteoprotegerin and receptor activator of nuclear factor kB ligand in the pathogenesis and treatment of rheumatoid arthritis. Arthritis Rheum 44:253\u2013259","journal-title":"Arthritis Rheum"},{"key":"701_CR4","first-page":"986","volume":"31","author":"Masi Laura","year":"2004","unstructured":"Laura Masi, Simonini G, Piscitelli E, Del Monte F, Giani T, Cimaz R et al (2004) Osteoprotegerin (OPG)\/RANK-L system in juvenile idiopathic arthritis: is there a potential modulating role for OPG\/RANK-L in bone injury? J Rheumatol 31:986\u2013991","journal-title":"J Rheumatol"},{"key":"701_CR5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/rheumatology\/keg037","volume":"42","author":"MJ Green","year":"2003","unstructured":"Green MJ, Gough AK, Devlin J et al (2003) Serum MMP-3, MMP-1, and progression of joint damage in early rheumatoid arthritis. Rheumatology (Oxford) 42:83\u201388","journal-title":"Rheumatology (Oxford)"},{"key":"701_CR6","first-page":"888","volume":"27","author":"C Ribbens","year":"2000","unstructured":"Ribbens C, Andre B, Jaspar JM et al (2000) Matrix metalloproteinase-3 serum levels are correlated with disease activity and predict clinical response in rheumatoid arthritis. J Rheumatol 27:888\u2013893","journal-title":"J Rheumatol"},{"key":"701_CR7","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/ard.59.6.455","volume":"59","author":"Y Yoshihara","year":"2000","unstructured":"Yoshihara Y, Nakamura H, Obata K et al (2000) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis 59:455\u2013461","journal-title":"Ann Rheum Dis"},{"key":"701_CR8","first-page":"1523","volume":"33","author":"M Fiedorczyk","year":"2006","unstructured":"Fiedorczyk M, Klimiuk PA, Sierakowski S, Gindzienska-Sieskiewicz E, Chwiecko J (2006) Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with early rheumatoid arthritis. J Rheumatol 33:1523\u20131529","journal-title":"J Rheumatol"},{"key":"701_CR9","first-page":"826","volume":"29","author":"M Gattorno","year":"2002","unstructured":"Gattorno M, Vignola S, Falcini F, Sabatini F, Buoncompagni A, Simonini G, Picco P, Pistoia V (2002) Serum and synovial fluid concentrations of matrix metalloproteinases 3 and its tissue inhibitor 1 in juvenile idiopathic arthritis. J Rheumatol 29:826\u2013831","journal-title":"J Rheumatol"},{"key":"701_CR10","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/rheumatology\/kei025","volume":"44","author":"NJ Khawajal","year":"2005","unstructured":"Peake NJ, Khawaja1 K, Myers A, Jones D, Cawston TE, Rowan AD, FosterHE (2005) Levels of matrix metalloproteinase (MMP)-1 in paired sera and synovial fluids of juvenile idiopathic arthritis patients: relationship to inflammatory activity, MMP-3 and tissue inhibitor of metalloproteinases-1 in a longitudinal study. Rheumatology (Oxford) 44:1383\u20131389","journal-title":"Rheumatology (Oxford)"},{"key":"701_CR11","first-page":"390","volume":"31","author":"RE Prttry","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P et al (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:390\u2013392","journal-title":"J Rheumatol"},{"issue":"5","key":"701_CR12","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/art.21784","volume":"54","author":"A Lurati","year":"2006","unstructured":"Lurati A, Pontikaki I, Teruzzi B, Desiati F, Gerloni V, Gattinara M, Cimaz R, Fantini F (2006) A comparison of response criteria to evaluate therapeutic response in patients with juvenile idiopathic arthritis treated with methotrexate and\/or anti-tumor necrosis factor alpha agents. Arthritis Rheum 54(5):1602\u20131607","journal-title":"Arthritis Rheum"},{"key":"701_CR13","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1002\/art.21119","volume":"52","author":"S Viola","year":"2005","unstructured":"Viola S, Felici E, Magni-Manzoni S, Pistorio A, Buoncompagni A, Ruperto N, Rossi F, Bartoli M, Martini A, Ravelli A (2005) Development and validation of a clinical index for assessment of long-term damage in juvenile idiopathic arthritis. Arthritis Rheum 52:2092\u20132102","journal-title":"Arthritis Rheum"},{"key":"701_CR14","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1002\/art.10388","volume":"46","author":"M Ziolkowska","year":"2002","unstructured":"Ziolkowska M, Kurowska A, Radzikowska A et al (2002) High levels of osteoprotegerin and soluble receptor activator of nuclear factor kappa B ligand in serum of rheumatoid arthritis patients and their normalization after anti-tumor necrosis factor alpha treatment. Arthritis Rheum 46:1744\u20131753","journal-title":"Arthritis Rheum"},{"key":"701_CR15","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1006\/bbrc.2000.3379","volume":"275","author":"T Nakashima","year":"2000","unstructured":"NakashimaT, Kobayashi Y, Yamasaki S et al (2000) Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines. Biochem Biophys Res Commun 275:768\u2013775","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-007-0701-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-007-0701-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-007-0701-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:51:09Z","timestamp":1559119869000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-007-0701-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,17]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["701"],"URL":"https:\/\/doi.org\/10.1007\/s10067-007-0701-3","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,17]]}}}